- Home
- SLND vs RPID Comparison
SLND vs RPID Comparison
Compare SLND & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLND
- RPID
- Stock Information
- Founded
- SLND 1900
- RPID 2006
- Country
- SLND United States
- RPID United States
- Employees
- SLND N/A
- RPID N/A
- Industry
- SLND Military/Government/Technical
- RPID Medical Specialities
- Sector
- SLND Industrials
- RPID Health Care
- Exchange
- SLND Nasdaq
- RPID Nasdaq
- Market Cap
- SLND 175.8M
- RPID 155.6M
- IPO Year
- SLND N/A
- RPID 2021
- Fundamental
- Price
- SLND $3.80
- RPID $3.43
- Analyst Decision
- SLND Strong Buy
- RPID Buy
- Analyst Count
- SLND 1
- RPID 1
- Target Price
- SLND $5.00
- RPID $8.00
- AVG Volume (30 Days)
- SLND 47.1K
- RPID 85.4K
- Earning Date
- SLND 08-11-2025
- RPID 08-01-2025
- Dividend Yield
- SLND N/A
- RPID N/A
- EPS Growth
- SLND N/A
- RPID N/A
- EPS
- SLND N/A
- RPID N/A
- Revenue
- SLND $931,568,000.00
- RPID $29,645,000.00
- Revenue This Year
- SLND $3.76
- RPID $18.54
- Revenue Next Year
- SLND $1.08
- RPID $20.55
- P/E Ratio
- SLND N/A
- RPID N/A
- Revenue Growth
- SLND N/A
- RPID 28.36
- 52 Week Low
- SLND $1.85
- RPID $0.58
- 52 Week High
- SLND $4.93
- RPID $4.04
- Technical
- Relative Strength Index (RSI)
- SLND 50.65
- RPID 53.45
- Support Level
- SLND $3.66
- RPID $3.06
- Resistance Level
- SLND $4.28
- RPID $3.49
- Average True Range (ATR)
- SLND 0.22
- RPID 0.25
- MACD
- SLND -0.02
- RPID -0.06
- Stochastic Oscillator
- SLND 42.94
- RPID 54.43
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.